Unexpected effects of methylphenidate in attention-deficit/hyperactivity disorder reflect decreases in core/secondary symptoms and physical complaints common to all children

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 3, 2008, Pages 237-247

  Rapport, Mark D ^a,b   Kofler, Michael J ^a   Coiro, Maria M ^a   Raiker, Joseph S ^a   Sarver, Dustin E ^a   Alderson, R Matt ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b Department of Psychology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO; PSYCHOSTIMULANT AGENT;

ANGER; ANXIETY; APPETITE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CRYING; DAYDREAMING; DIZZINESS; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFECT; DYSURIA; FATIGUE; FEEDING BEHAVIOR; FEMALE; GASTROINTESTINAL SYMPTOM; HALO EFFECT; HEADACHE; HUMAN; HUMAN RELATION; HYPERACTIVITY; IMPULSIVENESS; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MOTOR COORDINATION; MUSCLE CRAMP; MYALGIA; NAUSEA; NOCTURNAL ENURESIS; PHYSICAL DISEASE; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; SIDE EFFECT; SITTING; SKIN PRURITUS; SLEEP DISORDER; STARING; STOMACH IRRITATION; SYMPTOMATOLOGY; VERBAL COMMUNICATION; XEROSTOMIA; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; INSOMNIA; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PHYSIOLOGICAL PROCESSES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 58149183966     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0140     Document Type: Article

References (68)

1. Abu-Arefeh I, Russell G: Recurrent limb pain in school. Arch Dis Child 74:336-339, 1996.
2. Achenbach TM: Empirically based assessment of child and adolescent disorders: Implications for diagnosis, classification, epidemiology, and longitudinal research. In: Children at Risk: Assessment, Longitudinal Research, and Intervention. Edited by Brambring M, Losel F. Oxford, England, Walter De Gruyter, 1989, pp 24-45.
3. Ahman PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant, RJ: Placebo controlled evaluation of Ritalin side effects. Pediatrics 91:1101-1106, 1993.
4. Aman MG, Marks RE, Tubott SH, Wilsher CP, Merry SN: Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. J Am Acad Child Adolesc Psychiatry 30:246-256, 1991.
5. th ed.). Washington, DC, American Psychiatric Association, 2000.
6. nd ed.). London, Blackwell, 1975.
7. Barea LM, Tannhauser M, Rotta NT: An epidemiologic study of headache among children and adolescents of southern Brazil. Cephalalgia 16:545-550, 1996.
8. Barkley RA, McMurray MB, Edelbrock CS, Robbins K: Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systematic, placebo-controlled evaluation. Pediatrics 86:184-192, 1990.
9. Barkley RA: Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (3rd edition). New York, Guildford Press, 2006.
10. Beidel DC, Christ MA, Long PJ: Somatic complaints in anxious children. J Abnorm Child Psychol 19:659-670, 1991.
11. Belmaker E, Espinoza R, Pogrund R: Use of medical services by adolescents with non-specific somatic symptoms. Int J Adolesc Med Health 1:150-156, 1985.
12. Campo JV, Fritsch SL: Somatization in children and adolescents. J Am Acad Child Adolesc Psychiatry 33:1223-1235, 1994.
13. Carlson GA, Kashani JH: Phenomenology of major depression from childhood through adulthood: Analysis of three studies. Am J Psychiatry 145:1222-1225, 1988.
14. Chronis, AM, Chacko, A, Fabiano, GA, Wymbs, BT, & Pelham, WE: Enhancements to the behavioral parent training paradigm for families of children with ADHD: Review and future directions. Clin Child Fam Psychol Rev 7: 1-27, 2004.
15. Clark LA, Watson D: Constructing validity: Basic issues in objective scale development. Psychol Assess 7:309-319, 1995.
16. Connor DF: Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. Int J Ment Health, 4:61-74, 2002
17. Conners CK, Epstein JN, March JS: Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 40:159-167, 2001.
18. Conners CK, Sitarenios G, Parker JDA, & Epstein JN: Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26: 279-291, 1998.
19. Denney CB, Rapport MD: Cognitive pharmacology of stimulants in children with ADHD. In: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. Edited by Solanto MV, Amsten AFT. New York, Oxford University Press, 2001, pp 283-302.
20. Dunn LM, Dunn LM: Peabody Picture Vocabulary Test-Third Edition. Circle Press, Minn.: American Guidance Service, 1997.
21. DuPaul GJ, Rapport MD: Does methylphenidate normalize the classroom performance of children with attention deficit disorder? J Am Acad Child Adolesc Psychiatry 32:190-198, 1993.
22. DuPaul GJ, Anastopoulos AD, Kwasnick D, Barkley RA, McMurray MB: Methylphenidate effects on children with attention deficit hyperactivity disorder: Self-report symptoms, side effects and self-esteem. J Atten Disord 1:3-15, 1996.
23. DuPaul GJ, Eckert TL: Interventions for students with Attention-Deficit/Hyperactivity Disorder: One size does not fit all. School Psych Rev 26:369-381, 1997.
24. Efron D, Jarman F, Barker M: Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics 100:662-666, 1997.
25. Egger H, Costello EJ, Angold A: Headaches and psychopathology in children and adolescents. J Am Acad Child Adolesc Psychiatry 37:951-958, 1999.
26. Faraone SV, Biederman J, Roe C: Comparative efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: A meta-analysis. J Clin Psychopharmacol 22:468-473, 2002.
27. Findling RL, Short EJ, Manos MJ: Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adoelsc Psychiatry 40:1441-1447, 2001.
28. Fine S, Johnston C: Drug and placebo side effects in methylphenidate- placebo trial for attention deficit hyperactivity disorder. Child Psychiatry Hum Dev 24: 25-30, 1993.
29. Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S: Short-term side effects of stimulant medication are increased in preschool children with attention deficit hyperactivity disorder: A double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 8:13-25, 1998.
30. Fischer M, Newby RF: Assessment of stimulant response in ADHD children using a refined multimethod clinical protocol. J Clin Child Adolesc Psychol 20:232-244, 1991.
31. Gadow J, Sverd J: Attention Deficit Hyperactivity Disorder, Chronic Tic Disorder, and Methylphenidate. In: Advances in Neurology: Tourette Syndrome Vol. 99. Edited by Walkup J, Mink J, Hollenbeck P. Philadelphia, Lippincott, 2006, pp 197-207.
32. Garber J, Walker L, Zeman J: Somatization symptoms in a community sample of children and adolescents: Further validation of the Children's Somatization Inventory. Psychol Assess 3:588-595, 1991.
33. Gittelman-Klein R, Klein DF: Methylphenidate effects in learning disabilities: Psychometric changes. Arch Gen Psychiatry, 33:655-664, 1976.
34. Gorman EB, Klorman R, Thatcher JE, Borgstedt AD: Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:808-816, 2006.
35. Grcevich S, Rowane WA, Marcellino B, Sullivan-Hurst S: Retrospective comparison of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol, 11:35-41, 2001.
36. Greenhill L, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, Arnold LE, Abikoff HB, Bukstein OG, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Wells K, Wigal T: Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. J Am Acad Child Adolesc Psychiatry, 40:180-187, 2001a.
37. Greenhill LL, Vitiello B, Abikoff H, Levine J, March JS, Riddle MA, Capasso L, Cooper T, Davies M Fisher P, Findling RL, Fried J, Labellarte M, McCracken J, McMahon DJ, Robinson J, Skrobala AM, Scahill L, Walkup J, Zito J: Improving the methods for evaluating the safety of psychotropic medications in children and adolescents. Current Therapeutic Res 62:873-884, 2001b.
38. Guy W: ECDEU Assessment Manual for Psychopharmacology (revised). Rockville, Maryland, Department of Health, Education and Human Welfare Publication No. (ADM) 76-338, 1976.
39. Handen BL, Breaux AM, Janosky J, McAuliffe S, Feldman H, Gosling H: Effects and noneffects of methylphenidate in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry 31:455-461, 1992.
40. Hollingshead AB: Four Factor Index of Social Status. New Haven (Connecticut), Yale University, 1975.
41. Jensen PS: Fact versus fancy concerning the multimodal treatment study for attention-deficit hyperactivity disorder. Can J Psychiatry 44:975-980, 1999.
42. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
43. rd ed.). Upper Saddle River (New Jersey), Prentice Hall, 1991.
44. King JE: Software solutions for obtaining kappa-type statistic for use with multiple raters. Dallas (Texas), Southwest Educational Research Association Annual Meeting, 2004.
45. Kollins SH, the PATS Study Group: Preschool ADHD Treatment Study. Phoenix (Arizona), National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting, 2004.
46. Last C: Somatic complaints in anxiety disordered children. J Anxiety Disord 5:125-138, 1991.
47. Linna S, Moilanen I, Keistinen H, Ernvall ML: Prevalence of psychosomatic symptoms in children. Psychother Psychosom 56:85-87, 1991.
48. Masi G, Favilla L, Millepiedi S, Mucci M: Somatic symptoms in children and adolescents referred for emotional and behavioral disorders. Psychiatry 63:140-149, 2000.
49. Mitchell EA, Aman MG, Turbott SH, Manku M: Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr (Phila) 26:406-411, 1987.
50. Multimodal Treatment Study of Children with ADHD Cooperative Group: Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The Multimodal treatment study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1088-1096, 1999.
51. rd ed.). New York, McGraw-Hill, 1994.
52. Pelham WE, McBurnett K, Harper GW, Milich R, Murphy DA, Clinton J, Thiele C: Methylphenidate and baseball playing in ADHD children: Who's on first? J Consult Clin Psychol 58:130-133, 1990.
53. Pine DS: Treating children and adolescents with selective serotonin reuptake inhibitors: How long is appropriate? J Child Adolesc Psychopharmacol 2:189-203, 2002.
54. Rapport MD, Kelley KL: Psychostimulant effects on learning and cognitive function: Findings and implications for children with attention deficit hyperactivity disorder. Clin Psychol Rev 11:61-92, 1991.
55. Rapport MD, Denney C, DuPaul GJ, Gardner MJ: Attention deficit disorder and methylphenidate: Normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 33:882-893, 1994.
56. Rapport MD, Denny C: Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: Is body mass predictive of clinical response? J Am Acad Child Adolesc Psychiatry 36:523-530, 1997.
57. Rapport MD, Chung K-M, Shore G, Issacs P: A conceptual model of child psychopathology: Implications for understanding attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol 30:48-58, 2001.
58. Rapport MD, Moffitt C: Attention-deficit/hyperactivity disorder and methylphenidate: A review of height/weight, cardiovascular, somatic complaint side effects. Clin Psychol Rev 22:1107-1131, 2002.
59. Rapport MD, Moffit C, Randall R: Attention-deficit/hyperactivity disorder and methylphenidate: A dose response analysis and parent-child comparisons of somatic complaints. J Atten Disord 6:15-24, 2002.
60. Routh DK, Schroeder CS, O'Tauma L: Development of activity level in children. Dev Psychol 10:163-168, 1974.
61. Short EJ, Manos MJ, Findling RL, Schubel EA: A prospective study of stimulant response in preschool children: Insights from ROC analyses. J Am Acad Child Adolesc Psychiatry 43:251-259, 2004.
62. Shrout PE, Fleiss JL: Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 2: 420-428, 1979.
63. Siegel S, Castellan NJ: Nonparametric Statistics for the Behavioural Sciences (2nd ed.). New York, McGraw-Hill, 1988.
64. Stewart-Williams S: The placebo puzzle: Putting together the pieces. Health Psychol 23:198-206, 2004.
65. Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G: Effects of stimulant medication on learning in children with ADHD. J Learn Disabil 24:219-230, 1991.
66. Swanson JM, Volkow ND: Pharmacokinetic and pharmacodynamic properties of stimulants: Implications for the design of new treatment for ADHD. Behav Brain Res 130:73-78, 2002.
67. Taylor DC, Szatmari P, Boyle MH, Offord DR: Somatization and the vocabulary of everyday bodily experiences and concerns: A community study of adolescents. J Am Acad Child Adolesc Psychiatry 35:491-499, 1996.
68. Vaessen W, & Van der Meere JJ: Issues in the selection of hyperactive/ADD(H) children for experimental clinical studies. In Developmental Biopsychology: Experimental and Observational Studies in Groups "at Risk". Edited by A. F. Kalverboer. Ann Arbor: University of Michigan Press, 1990, pp. 21-37.